Takeda's Partner Merges With Crestovo to Form Finch Therapeutics Group Post author:Sam Post published:October 22, 2017 Post category:BioPharma Two privately-held biotechs have merged to tackle recurrent C. difficile infections. Source: BioSpace You Might Also Like Third Rock Ventures Quietly Launches in Editas Medicine???s HQ March 6, 2017 3 Biotechs Facing Big FDA Decisions in October September 26, 2017 4 Solid Biotechs to Load Up on This Month December 3, 2017
